These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17136885)

  • 1. Aminoglycosides: ancient and modern.
    Davies JE
    J Antibiot (Tokyo); 2006 Sep; 59(9):529-32. PubMed ID: 17136885
    [No Abstract]   [Full Text] [Related]  

  • 2. Aminoglycoside microarrays to study antibiotic resistance.
    Disney MD; Magnet S; Blanchard JS; Seeberger PH
    Angew Chem Int Ed Engl; 2004 Mar; 43(12):1591-4. PubMed ID: 15022242
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of the regioselectivity for the staudinger reaction and its application for the synthesis of aminoglycosides with N-1 modification.
    Li J; Chiang FI; Chen HN; Chang CW
    J Org Chem; 2007 May; 72(11):4055-66. PubMed ID: 17465564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular understanding of aminoglycoside action and resistance.
    Jana S; Deb JK
    Appl Microbiol Biotechnol; 2006 Mar; 70(2):140-50. PubMed ID: 16391922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactams with or without aminoglycosides.
    Alfandari S; Boussekey N
    Clin Infect Dis; 2005 Nov; 41(10):1542-3; author reply 1543-4. PubMed ID: 16231273
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucopiericidin C: a cytotoxic piericidin glucoside antibiotic produced by a marine Streptomyces isolate.
    Shaaban KA; Helmke E; Kelter G; Fiebig HH; Laatsch H
    J Antibiot (Tokyo); 2011 Feb; 64(2):205-9. PubMed ID: 21081953
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of 6'- and 6'''-N-acylation of aminoglycosides as a strategy to overcome bacterial resistance.
    Shaul P; Green KD; Rutenberg R; Kramer M; Berkov-Zrihen Y; Breiner-Goldstein E; Garneau-Tsodikova S; Fridman M
    Org Biomol Chem; 2011 Jun; 9(11):4057-63. PubMed ID: 21365081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ups and downs of drug discovery: the early history of Fidaxomicin.
    McAlpine JB
    J Antibiot (Tokyo); 2017 May; 70(5):492-494. PubMed ID: 28096550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
    Yan RB; Yuan M; Wu Y; You X; Ye XS
    Bioorg Med Chem; 2011 Jan; 19(1):30-40. PubMed ID: 21177112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of six frequently isolated bacteria in intensive care unit patients to some cephalosporins and aminoglycosides.
    Carrington da Costa RB; Costa D; Pimentel J; Conçalves J; Rebelo A; Costa JJ
    J Chemother; 1989 Jul; 1(4 Suppl):323. PubMed ID: 16312421
    [No Abstract]   [Full Text] [Related]  

  • 11. 2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics.
    Busscher GF; Rutjes FP; van Delft FL
    Chem Rev; 2005 Mar; 105(3):775-91. PubMed ID: 15755076
    [No Abstract]   [Full Text] [Related]  

  • 12. Dimeric aminoglycosides as antibiotics.
    Agnelli F; Sucheck SJ; Marby KA; Rabuka D; Yao SL; Sears PS; Liang FS; Wong CH
    Angew Chem Int Ed Engl; 2004 Mar; 43(12):1562-6. PubMed ID: 15022234
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular insights into aminoglycoside action and resistance.
    Magnet S; Blanchard JS
    Chem Rev; 2005 Feb; 105(2):477-98. PubMed ID: 15700953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance to aminoglycosides among gram - negative bacteria].
    Akalin E; Baykal M
    Mikrobiyol Bul; 1982 Jan; 16(1):1-4. PubMed ID: 7144617
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-based design, synthesis and A-site rRNA co-crystal complexes of novel amphiphilic aminoglycoside antibiotics with new binding modes: a synergistic hydrophobic effect against resistant bacteria.
    Hanessian S; Pachamuthu K; Szychowski J; Giguère A; Swayze EE; Migawa MT; François B; Kondo J; Westhof E
    Bioorg Med Chem Lett; 2010 Dec; 20(23):7097-101. PubMed ID: 20970332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoglycoside resistance due to alterations of transport mechanisms.
    Stefani S; Russo G
    J Chemother; 1989 Jul; 1(4 Suppl):369-70. PubMed ID: 16312444
    [No Abstract]   [Full Text] [Related]  

  • 17. New Broad-Spectrum Antibacterial Amphiphilic Aminoglycosides Active against Resistant Bacteria: From Neamine Derivatives to Smaller Neosamine Analogues.
    Zimmermann L; Das I; Désiré J; Sautrey G; Barros R S V; El Khoury M; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2016 Oct; 59(20):9350-9369. PubMed ID: 27690420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases.
    Pokrovskaya V; Nudelman I; Kandasamy J; Baasov T
    Methods Enzymol; 2010; 478():437-62. PubMed ID: 20816493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside antibiotics in the 21st century.
    Becker B; Cooper MA
    ACS Chem Biol; 2013 Jan; 8(1):105-15. PubMed ID: 23110460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning the antibacterial activity of amphiphilic neamine derivatives and comparison to paromamine homologues.
    Zimmermann L; Bussière A; Ouberai M; Baussanne I; Jolivalt C; Mingeot-Leclercq MP; Décout JL
    J Med Chem; 2013 Oct; 56(19):7691-705. PubMed ID: 24083676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.